United Kingdom· GB-APID-4680811000001107
Bleo-Kyowa 15,000unit powder for solution for injection vials
A bleomycin product containing bleomycin, registered in United Kingdom by Kyowa Kirin Ltd. The same ATC class is registered in 15 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Bleomycin is registered in 15 of 19 countries.
Countries holding a registration under ATC L01DC01 (bleomycin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Bleomycin · ATC L01DC01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Bleomycin
- Manufacturer
- Kyowa Kirin Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01DC01
- ATC class
- Bleomycin
- Defined daily dose
- 3 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5702157107704
- gtin5038903000686
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
212 interactions on record for bleomycin.
Graded by severity as the source publishes them — 33 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bleomycin · interactions on record
212 records
- 33 severe
- 105 moderate
- 15 minor
- 59 info
Most severe, free to view
- CladribineL01BB04severe
- Brentuximab vedotinL01FX05severe
- Brentuximab vedotinL01XC12severe
- Talimogene laherparepvecL01XL02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bleomycin in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyBleo-CellStadapharm Gmbh
- NetherlandsBleomedac, poeder voor oplossing voor injectie 15000 IU (Ph. Eur.)Medac Gesellschaft für klinische Spezialpräparate mbH
- SpainBLEOMICINA ACCORD 15.000 UI POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFGAccord Healthcare S.L.U.
- FranceBLEOMYCINE ACCORD 15000 UI, poudre pour solution injectable / pour perfusionACCORD HEALTHCARE FRANCE
- SwedenBleomycin Accord 15000 IE Pulver till injektions-/infusionsvätska, lösningAccord Healthcare B.V.
- SwitzerlandBleomycin Baxter
- CanadaBLEOMYCIN FOR INJECTIONFRESENIUS KABI CANADA LTD
- NorwayBleomycin BaxterBaxter Medical AB
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Bleomycin Accord, Bleomycin Baxter
- Belgium · Bleomycine Accord
- Czechia · Bleomycin Accord
- Germany · Bleo-Cell, Bleomycin Accord
- Denmark · Bleomycin Accord, Bleomycin Baxter
- Spain · Bleomicina Accord, Bleomicina Viatris
- Finland · Bleomycin Accord
- France · Bleomycine Accord
- Iceland · Bleomycin Baxter
- Netherlands · Bleomycine Accord
- Norway · Bleomycin Accord, Bleomycin Baxter
- Poland · Bleomedac, Bleomycyna
- Portugal · Bleomicina Accord
- Romania · Bleomicină Accord
- Sweden · Bleomycin Accord, Bleomycin Baxter
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/346e3fcd-9896-4a54-9104-049bccaded4c GET /v1/drugs/346e3fcd-9896-4a54-9104-049bccaded4c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "4680811000001107",
"desc": "Bleo-Kyowa 15,000unit powder for solution for injection vials (Kyowa Kirin Ltd)",
"form": "Powder for solution for injection",
"vpid": "4694311000001105",
"source": "dmd",
"vtm_id": "774886000",
"strength": "15000 unit",
"substance": "Bleomycin",
"ingredient": "Bleomycin sulfate",
"supplier_code": "3558501000001106"
}See everything about bleomycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.